MCK

McKesson

519.82

1.01+0.19%

After Hours: 519.82 0.00 0.00%16:20 09/16 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE522.50/518.81

TODAY RANGE517.50-526.54

VOL642.04K

MARKET CAP67.41B

52 WEEK RANGE404.72-637.51

AVG VOL (3M)893.59K

% TURNOVER0.50%

TURNOVER--

P/E (TTM)23.26

% RANGE1.74%

EPS(TTM)22.35

P/E(FORWARD)16.38

P/B-38.4093

BVPS-13.5337

DIVIDEND2.840

P/S0.2187

BETA--

DIV YIELD0.55%

FREE FLOAT MKT CAP67.34B

SHARES OUTSTANDING129.68M

NEXT EARNINGS10/30-11/04

FREE FLOAT129.54M

LOT SIZE1

EX-DIV DATE08/30/2024

News

Press Releases

Financial Reports

Profile

Latest

Popular

Seeking Alpha·1d ago
McKesson - Meet The New Dividend Stock On My Watchlist
NASDAQ·2d ago
McKesson (MCK) Exceeds Market Returns: Some Facts to Consider
Dow Jones·3d ago
McKesson Price Target Cut to $535.00/Share From $576.00 by Wells Fargo
Dow Jones·3d ago
McKesson Is Maintained at Equal-Weight by Wells Fargo
TipRanks·3d ago
Michael Cherny Reaffirms Buy Rating on McKesson Amid Temporary Setbacks and Long-Term Growth Prospects
TipRanks·3d ago
Analysts Offer Insights on Healthcare Companies: Immuneering (IMRX), McKesson (MCK) and Neurocrine (NBIX)
Seeking Alpha·5d ago
IYK: A Low Volatility ETF For The Cautious Investor
Dow Jones·6d ago
McKesson Is Maintained at Buy by Citigroup
Dow Jones·6d ago
McKesson Price Target Cut to $630.00/Share From $670.00 by Citigroup
Seeking Alpha·6d ago
McKesson: The Correction Is Not Over
Seeking Alpha·6d ago
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2024 Update
NASDAQ·09/06 16:13
Validea Detailed Fundamental Analysis - MCK
NASDAQ·09/06 13:15
S&P Futures Rally After U.S. Jobs Report Released
TipRanks·09/06 09:49
Wells Fargo Gives a Hold Rating to McKesson (MCK)
TipRanks·09/06 09:05
Strategic Divestitures Bolster McKesson’s Focus on High-Growth Oncology Market: Maintaining Buy Rating

Same Industry

Name/Symbol

Change%

Price

McKesson

MCK

+0.19%

519.82

Biogen Inc

BIIB

+2.02%

199.58

Amgen Inc

AMGN

+0.85%

335.26

Shire

SHPG

179.20

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

0.00%

0.0300

Celgene

CELG

108.24

Lilly Eli & Co

LLY

-0.02%

923.54

Therapeuticsmd Inc

TXMD

-4.46%

1.710

Johnson & Johnson

JNJ

+0.89%

166.99

Abbvie Inc

ABBV

+0.78%

195.73

Zoetis Inc

ZTS

+1.65%

194.25

Gilead Sciences Inc

GILD

+0.42%

83.16

Novo-Nordisk A/S

NVO

-0.07%

136.90

Bristol-Myers Squibb Co

BMY

+1.75%

49.99

Alexion Pharms

ALXN

+1.70%

182.50

Pfizer

PFE

+2.73%

30.07

Sanofi FR

SNY

+0.35%

57.33

Sanofi FR

GCVRZ

0.00%

0.8711

Novartis

NVS

+1.12%

116.95

Dr Reddys Labs

RDY

-0.86%

79.68

GSK PLC

GSK

+1.26%

43.55

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.